{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:50:31Z","timestamp":1789426231304,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ando.2023.11.005","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T12:12:08Z","timestamp":1707135128000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Updates on the genetics of multiple endocrine neoplasia"],"prefix":"10.1016","volume":"85","author":[{"given":"Nicolas","family":"Sahakian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Romanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2023.11.005_bib0295","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2023.11.005_bib0300","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005792-196809000-00001","article-title":"Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2","volume":"47","author":"Steiner","year":"1968","journal-title":"Medicine"},{"key":"10.1016\/j.ando.2023.11.005_bib0305","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ando.2023.11.005_bib0310","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ando.2023.11.005_bib0315","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1073\/pnas.95.4.1630","article-title":"Menin, the product of the MEN1 gene, is a nuclear protein","volume":"95","author":"Guru","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2023.11.005_bib0320","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple Endocrine Neoplasia Type 1: Latest Insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2023.11.005_bib0330","first-page":"13","article-title":"Beyond the \u201c3 Ps\u201d: A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1","author":"Waguespack","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2023.11.005_bib0335","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2023.11.005_bib0340","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2015-3766","article-title":"Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group","volume":"101","author":"Van Leeuwaarde","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0345","first-page":"9","article-title":"The Importance of an Early and Accurate MEN1 Diagnosis","author":"De Laat","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2023.11.005_bib0350","first-page":"10","article-title":"Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2023.11.005_bib0355","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1086\/301729","article-title":"Characterization of mutations in patients with multiple endocrine neoplasia type 1","volume":"62","author":"Bassett","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ando.2023.11.005_bib0360","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/301953","article-title":"Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders","volume":"63","author":"Giraud","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ando.2023.11.005_bib0365","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10689-020-00186-1","article-title":"Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer","volume":"19","author":"Alhopuro","year":"2020","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ando.2023.11.005_bib0370","first-page":"14","article-title":"Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in BRCA2","author":"Hidalgo Mayoral","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ando.2023.11.005_bib0375","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-18-0852","article-title":"Diagnosis of mosaic mutations in the MEN1 gene by next generation sequencing","volume":"180","author":"Coppin","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.11.005_bib0380","first-page":"18","article-title":"Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller","author":"Xu","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ando.2023.11.005_bib0385","first-page":"11","article-title":"Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms","author":"Lagarde","year":"2022","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2023.11.005_bib0390","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-22-0171","article-title":"Multiple endocrine neoplasia type 1 caused by mosaic mutation: clinical follow-up and genetic counseling?","volume":"187","author":"Coppin","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.11.005_bib0395","unstructured":"MEN -1 mosaic: the founder of a family\/SFEBES2011\/Society for Endocrinology BES 2011\/Endocrine Abstracts n.d. https:\/\/www.endocrine-abstracts.org\/ea\/0025\/ea0025p196.(accessed September 25, 2023)."},{"key":"10.1016\/j.ando.2023.11.005_bib0400","doi-asserted-by":"crossref","first-page":"E4154","DOI":"10.1210\/clinem\/dgac454","article-title":"Early Detection of Relapse by ctDNA Sequencing in a Patient with Metastatic Thymic Tumor and MEN1 Mosaicism","volume":"107","author":"Lagarde","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0405","first-page":"6","article-title":"An Asymptomatic Case With MEN1 Slipping Through Genetic Screening by SNV-dependent Allelic Dropout","author":"Kosugi","year":"2022","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2023.11.005_bib0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-19-0522","article-title":"Whole genome sequencing of apparently mutation-negative MEN1 patients","volume":"182","author":"Backman","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.11.005_bib0415","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/excr.2000.5143","article-title":"p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer","volume":"264","author":"Philipp-Staheli","year":"2001","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ando.2023.11.005_bib0420","first-page":"3048","article-title":"Recessive transmission of a multiple endocrine neoplasia syndrome in the rat","author":"Andreas Fritz","year":"2002","journal-title":"PubMed"},{"key":"10.1016\/j.ando.2023.11.005_bib0425","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2023.11.005_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2009.02108.x","article-title":"Multiple endocrine neoplasias: advances and challenges for the future","volume":"266","author":"Alevizaki","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2023.11.005_bib0435","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ando.2022.07.044","article-title":"\u00c9tude des patients pris en charge en France pour suspicion de n\u00e9oplasie endocrinienne multiple de type 4 (NEM4): un travail r\u00e9trospectif multicentrique du r\u00e9seau TENGEN et du Groupe d\u2019\u00e9tude des tumeurs endocrines (GTE)","volume":"83","author":"Chevalier","year":"2022","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2023.11.005_bib0440","first-page":"30","article-title":"Germline CDKN1B variant type and site are associated with phenotype in MEN4","author":"Halperin","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.11.005_bib0445","first-page":"13","article-title":"Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management","author":"Lavezzi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2023.11.005_bib0450","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0455","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","article-title":"Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype","volume":"105","author":"Chasseloup","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0460","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1210\/clinem\/dgac162","article-title":"MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations","volume":"107","author":"Seabrook","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0465","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0470","first-page":"31","article-title":"Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1)","author":"Turner","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2023.11.005_bib0475","first-page":"12","article-title":"Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features","author":"Pardi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2023.11.005_bib0480","first-page":"4","article-title":"Multiple Endocrine Neoplasia Type 1 (MEN1) Phenocopy Due to a Cell Cycle Division 73 (CDC73) Variant","author":"Lines","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2023.11.005_bib0485","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-0476","article-title":"Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases","volume":"92","author":"Tham","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0490","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0003-4266(06)73010-4","article-title":"Contribution of genetic analysis in screening for MEN1 among patients with sporadic disease and one or more typical manifestation","volume":"67","author":"Odou","year":"2006","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2023.11.005_bib0495","first-page":"14","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.ando.2023.11.005_bib0500","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12020-019-01932-x","article-title":"True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome","volume":"65","author":"K\u00f6vesdi","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.11.005_bib0505","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.surg.2020.04.067","article-title":"Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies","volume":"169","author":"Pieterman","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.11.005_bib0510","first-page":"105","article-title":"Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly","author":"Nachtigall","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0515","author":"Goudet","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2023.11.005_bib0520","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000345667","article-title":"Multiple endocrine neoplasia type 2","volume":"41","author":"Lodish","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.ando.2023.11.005_bib0525","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2023.11.005_bib0530","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrendo.2011.139","article-title":"Management of medullary thyroid carcinoma and MEN2 syndromes in childhood","volume":"7","author":"Waguespack","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2023.11.005_bib0535","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2017-00317","article-title":"Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness","volume":"102","author":"Voss","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0540","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1210\/jc.2017-01146","article-title":"Letter to the Editor: \u201cMedullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness.\u201d","volume":"102","author":"Castinetti","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0545","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2019-00516","article-title":"Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center","volume":"104","author":"Raue","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0550","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejso.2020.09.004","article-title":"Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation","volume":"47","author":"Machens","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ando.2023.11.005_bib0555","first-page":"108","article-title":"The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative Medicine","author":"Machens","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.11.005_bib0560","first-page":"15","article-title":"Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET","author":"Sahakian","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ando.2023.11.005_bib0565","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2023.11.005_bib0570","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"Casco\u0144","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ando.2023.11.005_bib0575","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1055\/a-1186-0790","article-title":"Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion","volume":"52","author":"Petignot","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2023.11.005_bib0580","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T10:42:19Z","timestamp":1713177739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426624000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0003426624000106"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2023.11.005","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on the genetics of multiple endocrine neoplasia","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2023.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}